Honokiol DCA is an inhibitor of the phosphorylation of DRP1. It stimulates a phenotype suggestive of respiration through mitochondrial normalization and demonstrating activity in Vemurafenib-resistant melanoma in vivo. References: Bonner MY, Karlsson I, Rodolfo M, Arnold RS, Vergani E, Arbiser JL. Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo. Oncotarget. 2016 Mar 15;7(11):12857-68. doi: 10.18632/oncotarget.7289. PubMed PMID: 26871475; PubMed Central PMCID: PMC4914326.

纯度：≥98%

CAS：1620160-42-0